Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis
Abstract Background Switching biologic and targeted synthetic DMARDs (b/tsDMARD) is common in juvenile idiopathic arthritis (JIA) patients, though information about how this switching is done is scarce. This study aimed to determine the incidence rate, reasons for switching, and risk factors associa...
Saved in:
| Main Authors: | Daniel Clemente, Leticia Leon, Juan Carlos Nieto-Gonzalez, Alina Lucica Boteanu, Laura Trives Folguera, Antía Asunción García-Fernández, Helena Amar Muñoz, Aliuska Palomeque, Juan Carlos López Robledillo, Lydia Abasolo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Pediatric Rheumatology Online Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12969-025-01097-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of seropositive and seronegative rheumatoid arthritis patients using or about to be initiated with biological DMARDS
by: Zehra Özsoy, et al.
Published: (2025-03-01) -
Comparison of Efficacy and Safety of Single Versus Combination Dmard Therapy in Rheumatoid Arthritis-A Prospective Observational Study
by: Mayank P. Singh, et al.
Published: (2025-05-01) -
Perioperative management with DMARDs in rheumatic diseases: a scoping review of clinical guidelines
by: Alice Terrett, et al.
Published: (2025-07-01) -
Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast
by: Chiara Rizzo, et al.
Published: (2025-01-01) -
Outcomes of children with juvenile idiopathic arthritis receiving biological disease-modifying anti-rheumatic drugs: a retrospective single-centre experience from IndiaResearch in context
by: Pavneet Kaur, et al.
Published: (2025-07-01)